LifeStyle Constellation Brands Announces New Leadership Appointments Taner Halicioglu Dec 9, 2023 VICTOR, N.Y., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol… Read More...
LifeStyle Tyson Foods Opens Innovative New Fully-Cooked Food Production Plant in Virginia to Drive Business… Taner Halicioglu Nov 30, 2023 DANVILLE, Va., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Tyson Foods has officially opened a new $300 million fully-cooked… Read More...
Business CPI Aero Receives $9.6 Million Purchase Orders From U.S. Air Force for T-38 Aircraft Modification… Nick J Adam Nov 9, 2023 EDGEWOOD, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE… Read More...
Health AnaptysBio- and GSK-Partnered Immuno-Oncology Agent JEMPERLI (dostarlimab-gxly) plus Chemotherapy… James Pereira Aug 1, 2023 JEMPERLI is the first immuno-oncology treatment approved in the frontline setting for this patient population in… Read More...
Health Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY®… James Pereira Jul 31, 2023 CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV),… Read More...
Health Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY®… James Pereira Jul 31, 2023 CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV),… Read More...
Health Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO… James Pereira Jul 31, 2023 Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30 million… Read More...
Health TransCode Therapeutics Announces Positive Results in Non-human Primates with its Lead Therapeutic… James Pereira Jul 31, 2023 BOSTON, July 31, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company… Read More...
Health SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 30… James Pereira Jul 30, 2023 SYFOVRE reduced nonsubfoveal GA lesion growth by up to 45% between Months 24-30 compared to projected sham in the GALE… Read More...
Business AMD Announces Plan to Invest Approximately $400 Million Over the Next Five Years to Expand Research,… Nick J Adam Jul 30, 2023 GANDHINAGAR, India, July 28, 2023 (GLOBE NEWSWIRE) -- SemiconIndia 2023 — AMD (NASDAQ: AMD) today announced plans for… Read More...